|
1
|
Zeidan A, Purdham DM, Rajapurohitam V,
Javadov S, Chakrabarti S and Karmazyn M: Leptin induces vascular
smooth muscle cell hypertrophy through angiotensin II- and
endothelin-1-dependent mechanisms and mediates stretch-induced
hypertrophy. J Pharmacol Exp Ther. 315:1075–1084. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen NX, Kiattisunthorn K, O’Neill KD, et
al: Decreased microRNA is involved in the vascular remodeling
abnormalities in chronic kidney disease (CKD). PloS One.
8:e645582013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davis-Dusenbery BN, Wu C and Hata A:
Micromanaging vascular smooth muscle cell differentiation and
phenotypic modulation. Arterioscler Thromb Vasc Biol. 31:2370–2377.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kothapalli D, Castagnino P, Rader DJ,
Phillips MC, Lund-Katz S and Assoian RK: Apolipoprotein E-mediated
cell cycle arrest linked to p27 and the Cox2-dependent repression
of miR221/222. Atherosclerosis. 227:65–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bohlen F, Kratzsch J, Mueller M, et al:
Leptin inhibits cell growth of human vascular smooth muscle cells.
Vascul Pharmacol. 46:67–71. 2007. View Article : Google Scholar
|
|
6
|
Bodary PF, Shen Y, Ohman M, et al: Leptin
regulates neointima formation after arterial injury through
mechanisms independent of blood pressure and the leptin
receptor/STAT3 signaling pathways involved in energy balance.
Arterioscler Thromb Vasc Biol. 27:70–76. 2007. View Article : Google Scholar
|
|
7
|
Beltowski J: Leptin and atherosclerosis.
Atherosclerosis. 189:47–60. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davis R, Pillai S, Lawrence N, Sebti S and
Chellappan SP: TNF-α-mediated proliferation of vascular smooth
muscle cells involves Raf-1-mediated inactivation of Rb and
transcription of E2F1-regulated genes. Cell Cycle. 11:109–118.
2012. View Article : Google Scholar :
|
|
9
|
Gao X, Belmadani S, Picchi A, et al: Tumor
necrosis factor-alpha induces endothelial dysfunction in Lepr(db)
mice. Circulation. 115:245–254. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rajesh M, Mukhopadhyay P, Haskó G, Huffman
JW, Mackie K and Pacher P: CB2 cannabinoid receptor agonists
attenuate TNF-alpha-induced human vascular smooth muscle cell
proliferation and migration. Br J Pharmacol. 153:347–357. 2008.
View Article : Google Scholar
|
|
11
|
Lee SJ, Kim WJ and Moon SK: TNF-alpha
regulates vascular smooth muscle cell responses in genetic
hypertension. Int Immunopharmacol. 9:837–843. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rho MC, Ah Lee K, Mi Kim S, et al:
Sensitization of vascular smooth muscle cell to TNF-alpha-mediated
death in the presence of palmitate. Toxicol Appl Pharmacol.
220:311–319. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song B, Wang Y, Xi Y, et al: Mechanism of
chemoresistance mediated by miR-140 in human osteosarcoma and colon
cancer cells. Oncogene. 28:4065–4074. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu X, Li Z, Shen J, et al: MicroRNA-10b
promotes nucleus pulposus cell proliferation through RhoC-Akt
pathway by targeting HOXD10 in intervetebral disc degeneration.
PloS One. 8:e830802013. View Article : Google Scholar :
|
|
15
|
Hutcheson R, Terry R, Chaplin J, et al:
MicroRNA-145 restores contractile vascular smooth muscle phenotype
and coronary collateral growth in the metabolic syndrome.
Arterioscler Thromb Vasc Biol. 33:727–736. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martello G, Rosato A, Ferrari F, et al: A
MicroRNA targeting dicer for metastasis control. Cell.
141:1195–1207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Majid S, Dar AA, Saini S, et al:
MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in
bladder cancer. PloS One. 8:e676862013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu WK, Lee CW, Cho CH, et al: MicroRNA
dysregulation in gastric cancer: a new player enters the game.
Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brenner B, Hoshen MB, Purim O, et al:
MicroRNAs as a potential prognostic factor in gastric cancer. World
J Gastroenterol. 17:3976–3985. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cullen BR: MicroRNAs as mediators of viral
evasion of the immune system. Nat Immunol. 14:205–210. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rotllan N and Fernández-Hernando C:
MicroRNA regulation of cholesterol metabolism. Cholesterol.
2012:8478492012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen KC and Juo SH: MicroRNAs in
atherosclerosis. Kaohsiung J Med Sci. 28:631–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen LJ, Lim SH, Yeh YT, Lien SC and Chiu
JJ: Roles of microRNAs in atherosclerosis and restenosis. J Biomed
Sci. 19:792012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun Y, Chen D, Cao L, et al: MiR-490-3p
modulates the proliferation of vascular smooth muscle cells induced
by ox-LDL through targeting PAPP-A. Cardiovasc Res. 100:272–279.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu ML, Wang JF, Wang GK, et al: Vascular
smooth muscle cell proliferation is influenced by let-7d microRNA
and its interaction with KRAS. Circ J. 75:703–709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim S and Kang H: miR-15b induced by
platelet-derived growth factor signaling is required for vascular
smooth muscle cell proliferation. BMB Rep. 46:550–554. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li P, Liu Y, Yi B, et al: MicroRNA-638 is
highly expressed in human vascular smooth muscle cells and inhibits
PDGF-BB-induced cell proliferation and migration through targeting
orphan nuclear receptor NOR1. Cardiovasc Res. 99:185–193. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gómez-Hernández A, Escribano Ó, Perdomo L,
et al: Implication of insulin receptor A isoform and IRA/IGF-IR
hybrid receptors in the aortic vascular smooth muscle cell
proliferation: role of TNF-α and IGF-II. Endocrinology.
154:2352–2364. 2013. View Article : Google Scholar
|
|
29
|
Jiang F, Jiang R, Zhu X, Zhang X and Zhan
Z: Genipin inhibits TNF-α-induced vascular smooth muscle cell
proliferation and migration via induction of HO-1. PloS One.
8:e748262013. View Article : Google Scholar
|
|
30
|
Kim HH and Kim K: Enhancement of
TNF-alpha-mediated cell death in vascular smooth muscle cells
through cytochrome c-independent pathway by the proteasome
inhibitor. FEBS Lett. 535:190–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Q, Zou C, Han Z, et al: MicroRNA-25
functions as a potential tumor suppressor in colon cancer by
targeting Smad7. Cancer Lett. 335:168–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Razumilava N, Bronk SF, Smoot RL, et al:
miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death
receptor-4 and promotes apoptosis resistance in cholangiocarcinoma.
Hepatology. 55:465–475. 2012. View Article : Google Scholar :
|
|
33
|
Lu D, Davis MP, Abreu-Goodger C, et al:
MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse
fibroblast cells to iPSCs. PloS One. 7:e409382012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Su ZX, Zhao J, Rong ZH, Geng WM, Wu YG and
Qin CK: Upregulation of microRNA-25 associates with prognosis in
hepatocellular carcinoma. Diagn Pathol. 9:472014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu FX, Su YL, Zhang H, Kong JY, Yu H and
Qian BY: Prognostic implications for high expression of MiR-25 in
lung adenocarcinomas of female non-smokers. Asian Pac J Cancer
Prev. 15:1197–1203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Esposito F, Tornincasa M, Pallante P, et
al: Down-regulation of the miR-25 and miR-30d contributes to the
development of anaplastic thyroid carcinoma targeting the polycomb
protein EZH2. J Clin Endocrinol Metab. 97:E710–E718. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li X, Yang C, Wang X, Zhang J, Zhang R and
Liu R: The expression of miR-25 is increased in colorectal cancer
and is associated with patient prognosis. Med Oncol. 31:7812014.
View Article : Google Scholar
|
|
38
|
Wahlquist C, Jeong D, Rojas-Muñoz A, et
al: Inhibition of miR-25 improves cardiac contractility in the
failing heart. Nature. 508:531–535. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Setyowati Karolina D, Sepramaniam S, Tan
HZ, Armugam A and Jeyaseelan K: miR-25 and miR-92a regulate insulin
I biosynthesis in rats. RNA Biol. 10:1365–1378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang H, Zuo Z, Lu X, Wang L, Wang H and
Zhu Z: MiR-25 regulates apoptosis by targeting Bim in human ovarian
cancer. Oncol Rep. 27:594–598. 2012.
|
|
41
|
Grossel MJ and Hinds PW: Beyond the cell
cycle: a new role for Cdk6 in differentiation. J Cell Biochem.
97:485–493. 2006. View Article : Google Scholar
|
|
42
|
Pauls E, Ruiz A, Badia R, et al: Cell
cycle control and HIV-1 susceptibility are linked by CDK6-dependent
CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells. J
Immunol. 193:1988–1997. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kohrt D, Crary J, Zimmer M, et al: CDK6
binds and promotes the degradation of the EYA2 protein. Cell Cycle.
13:62–71. 2014. View Article : Google Scholar :
|
|
44
|
Wu J, Qian J, Li C, et al: miR-129
regulates cell proliferation by downregulating Cdk6 expression.
Cell Cycle. 9:1809–1818. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dauphinot L, De Oliveira C, Melot T, et
al: Analysis of the expression of cell cycle regulators in Ewing
cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression.
Oncogene. 20:3258–3265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kollmann K and Sexl V: CDK6 and p16INK4A
in lymphoid malignancies. Oncotarget. 4:1858–1859. 2013.PubMed/NCBI
|
|
47
|
Liu B, Han M, Sun RH, Wang JJ, Liu YP and
Wen JK: Acetylbritannilactone induces G1 arrest and apoptosis in
vascular smooth muscle cells. Int J Cardiol. 149:30–38. 2011.
View Article : Google Scholar
|
